August 2022 - Combat Group

“If we could kill the tumour without radical surgery, boy would that be a boon for patients. And I think that’s where we are headed”

by Combat Cancer | Aug 23, 2022 | The Medical Innovators Interview

The Medical Innovators Interview with Professor Brant Inman | July 2022 From superheated nanoparticles to intravesical therapy and barriers to change in bladder-cancer treatment – there’s plenty of food for thought in our July Medical Innovators interview, with...

Growing data points towards use of HIVEC® in high-risk and BCG-unresponsive patients following publication of HIVEC® bladder cancer RCT results

by Combat Cancer | Aug 22, 2022 | News

Press release, 22 August 2022 Combat Medical is pleased to announce the results of the HIVEC® II trial, published in European Urology on 20 August 20221. It is one in a series of recent HIVEC® publications helping chemo-hyperthermia to find its place in the treatment...

“There’s a new vitality in bladder cancer. And it’s exciting to have come through 20 years of agony and start to see the fruits of all that labour”

by Combat Cancer | Aug 16, 2022 | The Medical Innovators Interview

The Medical Innovators Interview with Professor Michael O’Donnell | June 2022 Gem/doce vs BCG, quantum dots and the future of uro-oncology come under the microscope in our June Medical Innovators Interview, with Combat Medical’s Guy Cooper in conversation...

“If we could kill the tumour without radical surgery, boy would that be a boon for patients. And I think that’s where we are headed”

Growing data points towards use of HIVEC® in high-risk and BCG-unresponsive patients following publication of HIVEC® bladder cancer RCT results

“There’s a new vitality in bladder cancer. And it’s exciting to have come through 20 years of agony and start to see the fruits of all that labour”

Recent Posts

Recent Comments

Archives

Categories

Meta